Exploring the evidence in support of collaborative care for depression in patients with coronary heart disease/diabetes: the COINCIDE long-term follow-up (COINCIDE 24)
Please note that this project finished in December 2015 and is no longer active.
What did we do?
The COINCIDE study provided good evidence of the short-term effectiveness of the COINCIDE collaborative care model as a treatment for depression in patients with long-term conditions. This work assessed the long-term effectiveness and cost-effectiveness of the intervention.
Why was it important?
When combined with a long-term condition, depression leads to the greatest reductions in quality of life. Depression and anxiety are known to drive unscheduled care in the health service, and the health economic impact of mental and physical multimorbidity is significant. Work by the King’s Fund has shown that depression increases the cost of care for patients with long-term conditions by at least 45%, or from £3910 to £5670 a year. Managing mental and physical multimorbidity is difficult and poses challenges for all health services.
How did we do it?
We assessed the evidence of the long-term effectiveness and cost-effectiveness of the COINCIDE intervention using the original trial cohort over a 24 month period.
View the analysis plan for the evaluation of the long-term clinical and cost-effectiveness of the COINCIDE collaborative care intervention, over 24 months. Please contact Liz Camacho if you have any questions.
For further information about the project, please contact Michael Spence, Programme Manager.
The key output from the original COINCIDE study is “Integrated primary care for patients with mental and physical multimorbidity: cluster randomised controlled trial of collaborative care for patients with depression comorbid with diabetes or cardiovascular disease“, a paper published in the BMJ in 2015.